59Curated trials
Enterprise Evidence Report · NR-REPORT-V2.0
Hong Kong
Neuroscience Intelligence
Hong Kong neuroscience evidence report: current clinical, research, institution and source-linked intelligence.
Evidence rank #38 of 50 · Data maturity A · Research score 30.5 · Data confidence 100.0 / 100 · Snapshot 2026-10-12 03:36 UTC.
20Recruiting trials
50Publications
9Institutions
Executive interpretation
Hong Kong ranks #38 in the current NeuroRisk evidence-ranked market layer. This ranking summarizes indexed clinical, publication and institution evidence; it is not a probability of commercial success and not an investment recommendation.
Methodology status
Methodology NR-REPORT-V2.0. No synthetic ML confidence is presented as scientific probability. Counts and source links below are tied to the generation snapshot.
Methodology →Leading sponsors
The Hong Kong Polytechnic University127 recruiting
The University of Hong Kong124 recruiting
Chinese University of Hong Kong111 recruiting
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.40 recruiting
Education University of Hong Kong31 recruiting
Merck Sharp & Dohme LLC32 recruiting
Hong Kong Metropolitan University11 recruiting
NovoCure GmbH10 recruiting
Region Skane11 recruiting
Shionogi10 recruiting
Disease activity
Autism9trials
Stroke8trials
Depression7trials
Alzheimers7trials
Epilepsy5trials
Parkinsons4trials
Adhd4trials
Other Neurology2trials
Pain Neuropathy2trials
Schizophrenia2trials
Research institutions
City University of Hong KongOpenAlexlinked institution
Hong Kong Polytechnic UniversityOpenAlexlinked institution
Lui Che Woo Institute of Innovative MedicineOpenAlexlinked institution
Chinese University of Hong KongOpenAlexlinked institution
Lingnan UniversityOpenAlexlinked institution
Hong Kong University of Science and TechnologyOpenAlexlinked institution
Hong Kong Baptist UniversityOpenAlexlinked institution
Princess Margaret HospitalOpenAlexlinked institution
University of Hong KongOpenAlexlinked institution
Clinical evidence trail
NCT07782177Optimizing Elderly Hearing Loss Care in Hong Kong A Cost-Effectiveness and Satisfactory Analysis of a Pilot Collaborative Model Between Otorhinolaryngologists and Family Medicine SpecialistsNOT_YET_RECRUITING
NCT07779863Acupressure as Long-term Intervention to Slow the Progression of Early/Mild Alzheimer's DiseaseNOT_YET_RECRUITING
NCT07441928Effects of Smoking on Network Connectivity in Patients With Schizophrenia Symptoms in Scz PatientsRECRUITING
NCT07392632MindfulCityU-- A Mindfulness Mobile Application for Promoting University Students' Mental HealthNOT_YET_RECRUITING
NCT07382336A Mobile Application for Early Detection and Symptoms Trajectories of Postpartum Depression Using Ecological Momentary Assessment (EMA)RECRUITING
NCT07308210Hybrid Computerized EF Training Using Virtual Human Stimuli for AutismACTIVE_NOT_RECRUITING
NCT07252739KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)RECRUITING
NCT07166978Improving Autistic Children's Experiences of Dental Care With Class-integrated Social StoryRECRUITING
NCT07052110DST in Reducing Depressive Symptoms, Enhancing Self-esteem, and Promoting Quality of Life Among CCSsRECRUITING
NCT06966700A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)RECRUITING
Research evidence trail
PUBMEDAssociation between lithium treatment and vascular calcification in bipolar disorder: A retrospective cohort study.2026-12-15
PUBMEDThe impact of insomnia and excessive daytime sleepiness on depression and suicidal ideation in adolescents: A three-year longitudinal study.2026-11-01
PUBMEDCorrigendum to "Evolving patterns of antipsychotic use and polypharmacy for schizophrenia in Hong Kong: a 21-year longitudinal study" [Psychiatry Research 364 (2026) 117346].2026-11-01
PUBMEDPatterns, predictors and outcomes of the joint trajectories of positive and negative symptoms in patients with early psychosis: 12-year follow-up of the randomized controlled trial on extended early intervention.2026-11-01
PUBMEDApplication of IgA-Seq in schizophrenia to identify key gut bacteria that promote abnormal behavior in mice.2026-10-07
PUBMEDEvolving patterns of antipsychotic use and polypharmacy for schizophrenia in Hong Kong: a 21-year longitudinal study.2026-10-01
PUBMEDAssociation of Prodromal Parkinson's Disease-Like Features in Long COVID With Dream-Enactment Behaviours.2026-10-01
PUBMEDChinese guidelines for diagnosis and treatment of intracranial atherosclerotic stenosis.2026-10-01
PUBMEDMulti-cohort evidence for impaired microbial support of the methionine cycle in children with autism spectrum disorder.2026-10-01
PUBMEDNon-pharmacological executive function interventions for children and adolescents with neurodevelopmental disorders: a systematic review and network meta-analysis.2026-10-01
PUBMEDWhite matter abnormalities in bipolar II and unipolar depression - Evidence from fixel-based analysis.2026-10-01
PUBMEDAntidepressant use and risk of bipolar disorder in children, adolescents and young adults with unipolar depression: a target trial emulation study.2026-10-01
Sources and provenance
ClinicalTrials.gov provides NCT evidence. PubMed/NCBI and OpenAlex provide research metadata. OpenAlex links institutions. World Bank indicators are included only when an explicit source row and year exist. NeuroRisk transformations add normalization, ranking and graph connections.
Limitations
Indexed corpus counts are not guaranteed exhaustive global totals. Scores are comparative decision-support signals. This report is not medical advice, regulatory advice, patent clearance, an investment recommendation or a guarantee of outcome.